<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92450">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01955954</url>
  </required_header>
  <id_info>
    <org_study_id>PAHS 1-001-13</org_study_id>
    <nct_id>NCT01955954</nct_id>
  </id_info>
  <brief_title>Using the Canary Breathing System for Panic Disorder Patients</brief_title>
  <official_title>Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Palo Alto Health Sciences, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Palo Alto Health Sciences, Inc.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the effectiveness of the Canary Breathing System (CBS)
      in treating the symptoms of panic disorder.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Score on the Panic Disorder Severity Scale</measure>
    <time_frame>Measured at 2 months past the last intervention.</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">47</enrollment>
  <condition>Panic Disorder</condition>
  <arm_group>
    <arm_group_label>Canary Breathing System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Canary Breathing System</intervention_name>
    <description>The Canary Breathing System is a biofeedback device meant to assist patients in the re-training of normal breathing patterns.</description>
    <arm_group_label>Canary Breathing System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary diagnosis of Panic Disorder

          -  Subjects between 18 and 60 years of age (inclusive on day of enrollment)

          -  Subjects with a Clinician's Global Impression of &gt; or = to 4.

          -  If on psychotropic medication, on a stable dose for a minimum of 3 months prior to
             enrollment

          -  If on psychotropic medication, an agreement to stay on their stable dose from study
             entry until the     2-month follow-up.

        Exclusion Criteria:

          -  Pregnancy

          -  Current enrollment in another drug or device study

          -  Current enrollment in another drug or device study that is not at least 30 days past
             the final follow-up

          -  Currently undergoing cognitive behavioral therapy (or equivalent)

          -  Refractory to either a breathing training program or cognitive behavioral therapy (or
             equivalent) in the 3 months prior to enrollment

          -  Evidence of organic mental disorder

          -  Severe suicidality

          -  Presence of any psychotic disorder

          -  Bipolar disorder that is present for &lt; 5 years; a major depressive, manic or
             hypomanic episode in the last 12 months; failure to take and maintain a stable dose
             of medication in treatment of bipolar disorder in the last 12 months

          -  Current alcohol or drug dependence

          -  Cardiovascular or pulmonary disease

          -  Epilepsy or seizures

          -  Undergoing additional psychologic treatment at any point from study enrollment to
             2-month follow-up to treat panic disorder
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Debra Reisenthel</last_name>
    <email>Debra@PAHealthSciences.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>San Francisco Bay Area Center for Cognitive Therapy</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94618</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadya Tannous</last_name>
      <phone>510-652-4455</phone>
      <phone_ext>6</phone_ext>
      <email>canarystudy@sfbacct.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute of Living</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marla Genova, MA</last_name>
      <phone>860-545-7707</phone>
      <email>Marla.Genova@hhchealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alexian Brothers Center for Anxiety and OCD</name>
      <address>
        <city>Hoffman Estates</city>
        <state>Illinois</state>
        <zip>60169</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Lee</last_name>
      <phone>847-230-3509</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kansas City Center for Anxiety Treatment, P.A.</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Becky Selover, MA</last_name>
      <phone>913-956-6210</phone>
      <email>research@kcanxiety.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 21, 2014</lastchanged_date>
  <firstreceived_date>September 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>carbon dioxide monitoring</keyword>
  <keyword>panic disorder</keyword>
  <keyword>biofeedback</keyword>
  <keyword>breathing training</keyword>
  <keyword>Primary diagnosis</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Panic Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
